ArticleCancer diagnosis & prognosis

Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive

Minehiko Inomata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.